USD 15.53  0.56  3.74%   

Market Performance
2 of 100
Odds Of Distress
Less than 48
ASTELLAS PHARMA is trading at 15.53 as of the 11th of August 2022, a 3.74 percent up since the beginning of the trading day. The stock's lowest day price was 15.53. ASTELLAS PHARMA has 48 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for ASTELLAS PHARMA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of August 2020 and ending today, the 11th of August 2022. Click here to learn more.
Fiscal Year End
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.85 B outstanding shares. More on ASTELLAS PHARMA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. ASTELLAS PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ASTELLAS PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Latest headline from IRONWOOD PHARMACEUTICALS INC Managements Discussion and Analysis of Financial Condition and Results of Operations -
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, ASTELLAS PHARMA's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ASTELLAS PHARMA's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEOYoshihiko Hatanaka
Excise Tax ActivitiesAnimal TestingCatholic
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ASTELLAS PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
ASTELLAS PHARMA [ALPMF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 29.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ASTELLAS PHARMA's market, we take the total number of its shares issued and multiply it by ASTELLAS PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ASTELLAS PHARMA classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.85 B outstanding shares. ASTELLAS PHARMA has accumulated about 337.28 B in cash with 257.44 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 184.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ASTELLAS PHARMA Probability Of Bankruptcy
ASTELLAS PHARMA holds a total of one billion eight hundred fifty million outstanding shares. Over half of ASTELLAS PHARMA outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Therefore, these institutions are subject to different rules and regulation than regular investors in ASTELLAS PHARMA. Please watch out for any change in the institutional holdings of ASTELLAS PHARMA as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check ASTELLAS Ownership Details

ASTELLAS Stock Price Odds Analysis

What are ASTELLAS PHARMA's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ASTELLAS PHARMA jumping above the current price in 90 days from now is about 33.0%. The ASTELLAS PHARMA probability density function shows the probability of ASTELLAS PHARMA otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon ASTELLAS PHARMA has a beta of 0.2119. This suggests as returns on the market go up, ASTELLAS PHARMA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ASTELLAS PHARMA will be expected to be much smaller as well. Additionally, the company has an alpha of 0.0407, implying that it can generate a 0.0407 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 15.53HorizonTargetOdds Above 15.53
66.69%90 days
Based on a normal probability distribution, the odds of ASTELLAS PHARMA to move above the current price in 90 days from now is about 33.0 (This ASTELLAS PHARMA probability density function shows the probability of ASTELLAS OTC Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. ASTELLAS PHARMA market risk premium is the additional return an investor will receive from holding ASTELLAS PHARMA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ASTELLAS PHARMA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ASTELLAS PHARMA's alpha and beta are two of the key measurements used to evaluate ASTELLAS PHARMA's performance over the market, the standard measures of volatility play an important role as well.

ASTELLAS Stock Against Markets

Picking the right benchmark for ASTELLAS PHARMA otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ASTELLAS PHARMA otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ASTELLAS PHARMA is critical whether you are bullish or bearish towards ASTELLAS PHARMA at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ASTELLAS PHARMA without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Crypto Correlations Now


Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

ASTELLAS PHARMA Corporate Directors

ASTELLAS PHARMA corporate directors refer to members of an ASTELLAS PHARMA board of directors. The board of directors generally takes responsibility for the ASTELLAS PHARMA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ASTELLAS PHARMA's board members must vote for the resolution. The ASTELLAS PHARMA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Yutaka Kase - Independent DirectorProfile
Hironobu Yasuda - Independent DirectorProfile
Naoki Okamura - Executive Officer, Director of Business PlanningProfile
Eisuke Nozawa - Executive Officer, Director of Pharmaceutical AffairsProfile


You need to understand the risk of investing before taking a position in ASTELLAS PHARMA. The danger of trading ASTELLAS PHARMA is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ASTELLAS PHARMA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ASTELLAS PHARMA. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ASTELLAS PHARMA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the ASTELLAS PHARMA information on this page should be used as a complementary analysis to other ASTELLAS PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for ASTELLAS OTC Stock analysis

When running ASTELLAS PHARMA price analysis, check to measure ASTELLAS PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ASTELLAS PHARMA is operating at the current time. Most of ASTELLAS PHARMA's value examination focuses on studying past and present price action to predict the probability of ASTELLAS PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ASTELLAS PHARMA's price. Additionally, you may evaluate how the addition of ASTELLAS PHARMA to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is ASTELLAS PHARMA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ASTELLAS PHARMA. If investors know ASTELLAS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ASTELLAS PHARMA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
28.7 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of ASTELLAS PHARMA is measured differently than its book value, which is the value of ASTELLAS that is recorded on the company's balance sheet. Investors also form their own opinion of ASTELLAS PHARMA's value that differs from its market value or its book value, called intrinsic value, which is ASTELLAS PHARMA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ASTELLAS PHARMA's market value can be influenced by many factors that don't directly affect ASTELLAS PHARMA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ASTELLAS PHARMA's value and its price as these two are different measures arrived at by different means. Investors typically determine ASTELLAS PHARMA value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ASTELLAS PHARMA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.